{"id":"betaglucin-soluble-gel-0-2","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL139578","moleculeType":"Small molecule","molecularWeight":"313.44"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Beta-glucans are polysaccharides derived from fungal cell walls that bind to complement receptor 3 (CR3) and dectin-1 on macrophages, neutrophils, and dendritic cells, triggering enhanced phagocytosis and cytokine production. This activation of innate immunity is proposed to improve immune surveillance and response to pathogens and potentially malignant cells.","oneSentence":"Betaglucin is a beta-glucan immunomodulator that enhances innate immune responses by activating pattern recognition receptors on immune cells.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:04:03.260Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer immunotherapy (adjunctive)"},{"name":"Immune enhancement in infectious diseases"}]},"trialDetails":[{"nctId":"NCT03901690","phase":"PHASE3","title":"Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study","status":"UNKNOWN","sponsor":"Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri","startDate":"2019-08-27","conditions":"Genital Wart Virus Infection","enrollment":102}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Betaglucin soluble gel 0.2%","genericName":"Betaglucin soluble gel 0.2%","companyName":"Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri","companyId":"centro-de-investigaciones-medicas-y-ensayos-clinicos-dr-italo-fabbri","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Betaglucin is a beta-glucan immunomodulator that enhances innate immune responses by activating pattern recognition receptors on immune cells. Used for Cancer immunotherapy (adjunctive), Immune enhancement in infectious diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}